HAL vs LPCN · P/E 9.3, $19.05B cap vs rev $11.2M
Halliburton Company (HAL) versus Lipocine Inc (LPCN) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported LPCN revenue for 2024-12-31 was $11.2M. Net income was $8.4K. Revenue was up 492.8% from 2023-12-31 to 2024-12-31. LPCN currently screens at market cap $19.3M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. LPCN currently screens at market cap $19.3M.
Not investment advice. Open the HAL and LPCN stock pages for the full models.
Not investment advice.